{
  "actions": [
    {
      "acted_at": "2017-05-04", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-05-04", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1049-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "Y000064", 
      "district": null, 
      "name": "Young, Todd C.", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-05-04", 
      "state": "IN", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-05-04", 
  "number": "1049", 
  "official_title": "A bill to allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s934-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Opioid Addiction Risk Transparency Act", 
  "sponsor": {
    "bioguide_id": "H001076", 
    "district": null, 
    "name": "Hassan, Margaret Wood", 
    "state": "NH", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-05-04", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Addiction Risk Transparency Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Addiction Risk Transparency Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Opioid Addiction Risk Transparency Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2017-06-19T22:15:21Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s1049.xml"
}